LU88579I2 - ATOVAQUONE et ses sels pharmaceutiquement acceptables (WELLVONE R) - Google Patents

ATOVAQUONE et ses sels pharmaceutiquement acceptables (WELLVONE R)

Info

Publication number
LU88579I2
LU88579I2 LU88579C LU88579C LU88579I2 LU 88579 I2 LU88579 I2 LU 88579I2 LU 88579 C LU88579 C LU 88579C LU 88579 C LU88579 C LU 88579C LU 88579 I2 LU88579 I2 LU 88579I2
Authority
LU
Luxembourg
Prior art keywords
wellvone
atovaquone
pharmaceutically acceptable
acceptable salts
alkyl
Prior art date
Application number
LU88579C
Other languages
English (en)
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of LU88579I2 publication Critical patent/LU88579I2/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/30Unsaturated compounds
    • C07C62/34Unsaturated compounds containing ether groups, groups, groups, or groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C46/00Preparation of quinones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C50/00Quinones
    • C07C50/26Quinones containing groups having oxygen atoms singly bound to carbon atoms
    • C07C50/32Quinones containing groups having oxygen atoms singly bound to carbon atoms the quinoid structure being part of a condensed ring system having two rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/08Saturated compounds having a carboxyl group bound to a six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/15Saturated compounds containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/16Unsaturated compounds
    • C07C61/39Unsaturated compounds containing six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C61/00Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C61/16Unsaturated compounds
    • C07C61/40Unsaturated compounds containing halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/08Saturated compounds containing ether groups, groups, groups, or groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C62/00Compounds having carboxyl groups bound to carbon atoms of rings other than six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C62/08Saturated compounds containing ether groups, groups, groups, or groups
    • C07C62/10Saturated compounds containing ether groups, groups, groups, or groups with a six-membered ring
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LU88579C 1983-04-14 1984-04-14 ATOVAQUONE et ses sels pharmaceutiquement acceptables (WELLVONE R) LU88579I2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838310141A GB8310141D0 (en) 1983-04-14 1983-04-14 Naphthoquinone derivatives

Publications (1)

Publication Number Publication Date
LU88579I2 true LU88579I2 (fr) 1995-03-01

Family

ID=10541105

Family Applications (1)

Application Number Title Priority Date Filing Date
LU88579C LU88579I2 (fr) 1983-04-14 1984-04-14 ATOVAQUONE et ses sels pharmaceutiquement acceptables (WELLVONE R)

Country Status (17)

Country Link
EP (1) EP0123238B1 (fr)
JP (1) JPS59205341A (fr)
AT (1) ATE27696T1 (fr)
AU (1) AU574353B2 (fr)
CY (1) CY1549A (fr)
DE (2) DE3464132D1 (fr)
DK (1) DK172273B1 (fr)
GB (1) GB8310141D0 (fr)
HK (1) HK56690A (fr)
IL (1) IL71545A (fr)
LU (1) LU88579I2 (fr)
MX (1) MX9202993A (fr)
MY (1) MY102117A (fr)
NL (1) NL950002I2 (fr)
PH (1) PH22018A (fr)
SG (1) SG39390G (fr)
ZA (1) ZA842797B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8310140D0 (en) * 1983-04-14 1983-05-18 Wellcome Found Antiprotozoal agents
US5175319A (en) * 1983-04-14 1992-12-29 Burroughs Wellcome Co. Naphthoquinone derivatives
EP0253501A3 (fr) * 1986-07-16 1990-04-04 Imperial Chemical Industries Plc Cycloalcoylméthylamines N-disubstituées utiles comme fongicides
DE3801743A1 (de) * 1987-07-03 1989-01-19 Bayer Ag Schaedlingsbekaempfungsmittel auf basis von substituierten 1,4-naphthochinonen und neue substituierte 1,4-naphthochinone
US5206268A (en) * 1988-08-16 1993-04-27 Burroughs Wellcome Co. Medicaments
GB8819477D0 (en) * 1988-08-16 1988-09-21 Wellcome Found Medicaments
AU633836B2 (en) * 1988-08-16 1993-02-11 Wellcome Foundation Limited, The Medicaments
US5225184A (en) * 1988-08-16 1993-07-06 Burroughs Wellcome Co. Medicaments
EP0567162A1 (fr) * 1989-09-22 1993-10-27 The Wellcome Foundation Limited Médicaments pour le traitement de la toxoplasmose
GB8921516D0 (en) * 1989-09-22 1989-11-08 Wellcome Found Medicaments
GB8923254D0 (en) * 1989-10-16 1989-12-06 Wellcome Found Medicaments
GB9126874D0 (en) * 1991-12-18 1992-02-19 Wellcome Found Medicaments
GB9207517D0 (en) * 1992-04-06 1992-05-20 Wellcome Found Heterocyclic compounds
GB9216859D0 (en) * 1992-08-07 1992-09-23 Wellcome Found Medicaments
GB9224739D0 (en) * 1992-11-26 1993-01-13 Wellcome Found Medicaments
GB9226905D0 (en) * 1992-12-24 1993-02-17 Wellcome Found Pharmaceutical preparation
US5856362A (en) * 1994-09-02 1999-01-05 Glaxo Wellcome Inc. Medicaments for the treatment of toxoplasmosis
AU2004320912A1 (en) * 2004-07-16 2006-04-27 Usv Limited Novel polymorphs of atovaquone and process of preparation thereof
BRPI0513951A (pt) * 2004-07-30 2008-05-20 Japan Health Science Found agente antiprotozoário
ITMI20070941A1 (it) * 2007-05-09 2008-11-10 Chimico Internazi0Nale S P A L Procedimento per la preparazione di naftochinoni trans2,3-disostituiti
CN101774901B (zh) * 2009-01-09 2012-10-03 武汉泰祥通生物技术有限公司 一种制备阿托伐醌的方法
EP2467358B1 (fr) 2009-08-20 2014-07-23 IPCA Laboratories Limited Nouveau complexe pour le traitement et/ou la prophylaxie d'infections parasitaires
GB2476644B (en) 2009-12-23 2012-11-14 Haomamedica Ltd 1,4-Dihydro-1,4-dioxonaphtalene derivatives for the treatment of osteoporosis
EP2651868A2 (fr) 2010-12-15 2013-10-23 Glaxo Group Limited Procédé pour la préparation de l'atovaquone
EP2845588A1 (fr) * 2013-09-09 2015-03-11 Centre National de la Recherche Scientifique (C.N.R.S.) Inhibiteurs PIN1 destiné à être utilisé dans la prévention et/ou le traitement de theileriosis et applications associées

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2553647A (en) * 1946-03-20 1951-05-22 Research Corp Naphthoquinone antimalarials
EG14152A (en) * 1977-11-22 1983-12-31 Wellcome Found Antitheilerial naphtoquinone derivatives

Also Published As

Publication number Publication date
AU574353B2 (en) 1988-07-07
MX9202993A (es) 1992-07-01
IL71545A0 (en) 1984-07-31
IL71545A (en) 1987-12-20
DE19475021I2 (de) 2001-08-02
ZA842797B (en) 1985-11-27
DK193584A (da) 1984-10-15
PH22018A (en) 1988-05-13
AU2679684A (en) 1984-10-18
JPH0533212B2 (fr) 1993-05-19
EP0123238A2 (fr) 1984-10-31
NL950002I2 (nl) 1998-04-01
EP0123238A3 (en) 1985-10-30
ATE27696T1 (de) 1987-06-15
DE3464132D1 (de) 1987-07-16
GB8310141D0 (en) 1983-05-18
MY102117A (en) 1992-03-31
NL950002I1 (nl) 1995-03-01
SG39390G (en) 1990-11-23
HK56690A (en) 1990-08-03
CY1549A (en) 1991-03-22
DK193584D0 (da) 1984-04-13
DK172273B1 (da) 1998-02-16
EP0123238B1 (fr) 1987-06-10
JPS59205341A (ja) 1984-11-20

Similar Documents

Publication Publication Date Title
LU88579I2 (fr) ATOVAQUONE et ses sels pharmaceutiquement acceptables (WELLVONE R)
FI853622L (fi) Diarylacetylener, deras framstaellning och anvaendning.
ES8604571A1 (es) Un derivado de indol-3-carboxamida
FI892675A (fi) 2,6-dihalogenpyridin-3 -karboxylsyraderivat och deras framstaellning.
SE8601824L (sv) Karbapenem-mellanprodukter
FI861118A (fi) Foereningar befraemjande radionukleiders maolspecificitet och anvaendning av dessa.
ES8602002A1 (es) Procedimiento para preparar nuevas 4-fenil-tetrahidrofurano-(2,3-c)priridinas
ES2051846T3 (es) 3,4-dihidro-2-alquil-3-oxo-n-aril-2h-(1)benzotieno(3,2-e)-1,2-tiazino-4-carboxamido-1,1-dioxidos.
GB1361777A (en) 3-alkoxy-5-substituted phenylacetic acids
BG35044A3 (en) Method for preparing 1- oxa- beta- lactamic antibiotics
ES8400384A1 (es) Procedimiento para la preparacion de derivados de carbaciclina.
AU566911B2 (en) Triazalo pyridoquinazolines and their use in the treatment of allergies
IT1186277B (it) Otturatore di macchine per fotoriproduzione,munito di sorgente luminosa
ES8301486A1 (es) Nuevos derivados 1-n-(x-hidroxi-w-aminoalcanoil)de 5,3'4'- tridesoxi-o 5,3,4'-tridesoxi-6'-n-metil-o 5,3',4',6 -tetra- desoxi-kanamicina b y produccion de los mismos
IT8546845A0 (it) Gruppo bivalente per l'effettuazione di iniezioni nel cavo orale
BG42002A3 (en) Method for preparing of alpha- cyano- 3- phenoxybenzyl- 2- (4- chlorophenyl)- isovaleriate
FI834783A0 (fi) Med stopventil och vaetskecirkulationspump foersedd bilens vaermecell
FR2128168A2 (en) Pyrazine carboxamido ethyl benzene sulphonyl ureas - - hypoglycemiants